Stockreport

Artelo Biosciences Selected For Oral Presentation At The 32nd Annual ICRS Symposium In Galway, Ireland [TheStreet.com]

Artelo Biosciences, Inc.  (ARTL) 
US:NASDAQ Investor Relations: artelobio.com/investors
PDF SOLANA BEACH, Calif., June 24, 2022 (GLOBE NEWSWIRE) -- (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develo [Read more]